Development of a novel Schiff base derivative for enhancing the anticancer potential of 5-aminolevulinic acid-based photodynamic therapy

被引：3
|
作者：
Shinohara, Yusei [1 ]
Endo, Yoshio [2 ]
Abe, Chiaki [3 ]
Shiba, Ikkyu [1 ]
Ishizuka, Masahiro [4 ]
Tanaka, Tohru [4 ]
Yonemura, Yutaka [5 ]
Ogura, Shun-Ichiro [6 ]
Tominaga, Masahide [7 ]
Yamada, Hisatsugu [8 ]
Uto, Yoshihiro [8 ]
机构：
[1] Tokushima Univ, Grad Sch Adv Technol & Sci, Tokushima, Japan
[2] Kanazawa Univ, Canc Res Inst, Cent Res Resource Branch, Kanazawa, Ishikawa, Japan
[3] Inst Biomed Res & Innovat, Dept Mol Life Sci, Kobe, Hyogo, Japan
[4] SBI Pharmaceut Co Ltd, Tokyo, Japan
[5] NPO Org Support Peritoneal Disseminat Treatment, Osaka, Japan
[6] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa, Japan
[7] Tokushima Univ, Grad Sch, Inst Hlth Sci, Tokushima, Japan
[8] Tokushima Univ, Grad Sch, Inst Biosci & Bioind, 2-1 Minamijosanjima Cho, Tokushima 7708506, Japan
来源：
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY | 2017年 / 20卷
关键词：
5-Aminolevulinic acid; Protoporphyrin IX; Photodynamic therapy; Schiff base; ACCUMULATION; EXPRESSION; MEMBRANE; ROLES; ABCG2; PEPT1; ABCB6;
D O I：
10.1016/j.pdpdt.2017.10.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5-Aminolevulinic acid (ALA), a precursor of protoporphyrin IX (PDX), is now widely used for photodynamic diagnosis (ALA-PDD) and photodynamic therapy (ALA-PDT) of various cancers. Recently, we found that treatment of cancer cells with the Schiff base derivative TX-816 along with ALA could significantly increase the efficacy of ALA-PDT. This enhancing effect of TX-816 on ALA-PDT is attributed to 3,5-dichlorosalicylaldehyde (DCSA), a molecule produced by the degradation of TX-816. Similar to TX-816, DCSA significantly enhances the effect of ALA-PDT. Furthermore, DCSA could restore the sensitivity of cancer cells that acquired resistance to ALA-PDT. These results indicate that DCSA, as well as TX-816, is a potent lead compound for the development of an ALA-PDT sensitizer. TX-816 might be a useful compound for designing prodrug-type ALA-PDT enhancers.
引用
收藏
页码：182 / 188
页数：7
相关论文
共 50 条
  • [31] 5-aminolevulinic acid-based photodynamic therapy for the treatment of two patients with extramammary Paget's disease
    Mikasa, K
    Watanabe, D
    Kondo, C
    Kobayashi, M
    Nakaseko, H
    Yokoo, K
    Tamada, Y
    Matsumoto, Y
    JOURNAL OF DERMATOLOGY, 2005, 32 (02): : 97 - 101
  • [32] Development of microemulsions to topically deliver 5-aminolevulinic acid in photodynamic therapy
    Pires de Campos Araujo, Luciana Mattoso
    Thomazine, Jose Antonio
    Vianna Lopez, Renata Fonseca
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2010, 75 (01) : 48 - 55
  • [33] 5-Aminolevulinic acid-based photodynamic therapy of chordoma: In vitro experiments on a human tumor cell line
    Cornelius, Jan F.
    Eismann, Lennert
    Ebbert, Lara
    Senger, Brigitte
    Petridis, Athanasios K.
    Kamp, Marcel Alexander
    Sorg, Ruediger V.
    Steiger, Hans Jakob
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2017, 20 : 111 - 115
  • [34] Cytoprotective induction of nitric oxide synthase in a cellular model of 5-aminolevulinic acid-based photodynamic therapy
    Bhowmick, Reshma
    Girotti, Albert W.
    CANCER RESEARCH, 2010, 70
  • [35] Chinese guidelines on the clinical application of 5-aminolevulinic acid-based photodynamic therapy in dermatology (2021 edition)
    Shi, Lei
    Wang, Hongwei
    Chen, Kun
    Yan, Jia
    Yu, Bo
    Wang, Shengchun
    Yin, Rui
    Nong, Xiang
    Zou, Xianbiao
    Chen, Zhou
    Li, Chengxin
    Chen, Liuqing
    Zhang, Chunlei
    Zhang, Furen
    Zheng, Heyi
    Zheng, Min
    Tu, Ping
    Xu, Jinhua
    Tao, Juan
    Kang, Xiaojing
    Zeng, Kang
    Lu, Yan
    Yu, Nan
    Lei, Xia
    Pan, Meng
    Ju, Qiang
    Gu, Heng
    Wang, Xiuli
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 35
  • [36] Synergistic interaction of 5-aminolevulinic acid-based photodynamic therapy with simultaneous hyperthermia in an osteosarcoma tumor model
    Yanase, Sigeaki
    Nomura, Jouji
    Matsumura, Yoshihiko
    Nagata, Takayuki
    Fujii, Tasuku
    Tagawa, Toshiro
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 29 (02) : 365 - 373
  • [37] Photodynamic therapy based on combined use of 5-aminolevulinic acid with a pheophorbide-a derivative for murine tumors
    Jin, ZH
    Miyoshi, N
    Ishiguro, K
    Takaoka, K
    Udagawa, T
    Tajiri, H
    Ueda, K
    Fukuda, M
    Kumakiri, M
    IN VIVO, 2000, 14 (04): : 529 - 533
  • [38] Photodynamic therapy and fluorescence diagnosis with 5-aminolevulinic acid
    Stepp, Herbert
    CYTOMETRY PART A, 2007, 71A (09) : 743 - 743
  • [39] The assessment of 5-aminolevulinic acid photodynamic therapy in glioblastomas
    Aebisher, David
    Mytych, Wiktoria
    Los, Aleksandra
    Dynarowicz, Klaudia
    Mysliwiec, Angelika
    Bartusik-Aebisher, Dorota
    ONCOLOGIE, 2025, 27 (01) : 15 - 27
  • [40] Topical 5-aminolevulinic acid photodynamic therapy for warts
    Chien, Hsiung-Fei
    Liao, Yi-Hua
    Chen, Chin-Tin
    LASERS IN SURGERY AND MEDICINE, 2007, : 57 - 57
12345